Article abstract-A 23-year-old man with Pelizaeus-Merzbacher disease had a novel mutation, C344A (Thrll5Lys1, in exon 3 of the proteolipid protein gene (PLP). His mother, heterozygous for the mutation, developed progressive personality change and a gait disorder in her mid-20s. Her MRI at age 53 showed a diffuse severe leukodystrophy. This report extends the phenotypic range of disease due to PLP gene mutations to include adult-onset dementia in females. NEUROLOGY 1996;47:1333-1335 M.A. Nance, MD; S. Boyadjiev Case report. The propositus was born after a normal pregnancy, labor, and delivery to a 29-year-old woman and her 59-year-old husband. Gait abnormality was noticed a t 12 months and "cerebellar signs" at age 2. By age 4, pendular nystagmus in primary gaze and vertical nystagmus in the right eye were noted. There were delays in gross motor, fine motor, and language development; weakness of the legs with hyperreflexia; and positive Babinski signs. Laboratory evaluation included the following normal studies: brain scan, pneumoencephalogram, spinal fluid analysis, urine metabolic screen, skull x-ray, cervical myelogram, EEG, CBC, electrolytes, ECG, IgG, and CK. Lysine, ornithine, and serine were mildly elevated in one plasma sample. Bone marrow biopsy a t age 4 showed slightly increased cells, increased iron storage, and mild normoblastic hyperplasia. Liver biopsy a t that time showed mild fatty metamorphosis and pigment deposition. EEGs at ages 11 and 25 showed background slowing. Head CT at age 11 showed ventricular asymmetry. Lysosomal inclusions (fingerprint bodies) were present in 10% of lymphocytes a t age 25. Nerve conduction velocities were normal. The clinical diagnosis of PMD was made after MRI showed abnormal cerebral white matter suggestive of a leukodystrophy (figure 1, A and B).
PLP analysis has led to recognition of several PLPrelated disease phenotypes, including "classical" PMD, spastic paraplegia, and variable symptoms in heterozygous women. Adult-onset neurodegenerative disorder is a phenotype previously unrecognized among female PLP mutation carriers.
Case report. The propositus was born after a normal pregnancy, labor, and delivery to a 29-year-old woman and her 59-year-old husband. Gait abnormality was noticed a t 12 months and "cerebellar signs" at age 2. By age 4, pendular nystagmus in primary gaze and vertical nystagmus in the right eye were noted. There were delays in gross motor, fine motor, and language development; weakness of the legs with hyperreflexia; and positive Babinski signs. Truncal and limb ataxia were mild. Head circumference was normal. A progressive gait disorder caused him to be wheelchair-bound by his late teens. Serial psychometric evaluations showed stable scores of verbal I& 81, performance I& 59, full-scale I& 70, memory quotient 67 (scores at age 23). At age 25, he had a euphoric affect, slow dysarthric speech, constant shimmering eye movements, nystagmus, normal fundi, mild right arm and facial weakness, decreased cough reflex, spastic paraplegia, mild cogwheeling rigidity of the left arm, truncal titubation, mild resting and action tremor, dystonic posturing of the left hand, normal sensory examination, and brisk reflexes.
Laboratory evaluation included the following normal studies: brain scan, pneumoencephalogram, spinal fluid analysis, urine metabolic screen, skull x-ray, cervical myelogram, EEG, CBC, electrolytes, ECG, IgG, and CK. Lysine, ornithine, and serine were mildly elevated in one plasma sample. Bone marrow biopsy a t age 4 showed slightly increased cells, increased iron storage, and mild normoblastic hyperplasia. Liver biopsy a t that time showed mild fatty metamorphosis and pigment deposition. EEGs at ages 11 and 25 showed background slowing. Head CT at age 11 showed ventricular asymmetry. Lysosomal inclusions (fingerprint bodies) were present in 10% of lymphocytes a t age 25. Nerve conduction velocities were normal. The clinical diagnosis of PMD was made after MRI showed abnormal cerebral white matter suggestive of a leukodystrophy (figure 1, A and B).
The proband's mother graduated from high school after a normal childhood and adolescence and worked in a restaurant. "Nervousness" was noted by the family when she was in her mid-20s. By age 31, a gait disorder was noticeable. She gradually lost the ability to walk or care for herself and was placed in a nursing home a t age 44.
At age 53, she was well-nourished but had contractures of fingers, wrists, elbows, ankles, and knees. She did not vocalize to command or pain. She occasionally followed or mimicked simple commands such as "open mouth." The eyes showed spontaneous roving movements, but it was unclear whether she tracked objects visually or not. She drooled and was unable to protrude her tongue. There was stereotyped movement of the right arm to scratch the forehead, but no other spontaneous movement. The legs did not move to painful stimuli. Tone was markedly increased, and reflexes were very brisk with sustained clonus at the ankles. There was occasional extensor posturing of the arms with stimulation. There was an indwelling Foley catheter because of a neurogenic bladder. Cerebral MRI is shown in figure 2 .
No other affected individuals are known in the family. PLP analysis. Single-strand conformation polymorphism (SSCP) was performed as described.' The PLP exons were amplified and sequenced as described by Pratt et aL2 Single nucleotide primer extension (SNuPE) was performed as d e~c r i b e d .~ The SNuPE primer was 5 ' -CGGCAAGGGCCTGAGCGCAA-3'. a-"P dATP was used to detect the mutation-containing allele and ( Y -~~P dTTP was used as a negative control.
SSCP analysis revealed a shift in exon 3 of the proband's DNA. The exon was sequenced and a C to A transversion was found at nucleotide 344, resulting in the substitution of Lys ( U G ) for Thr (ACG) at codon 115. The mutation, which is also present in the mother, can be detected by direct sequencing (figure 3A) or by SNuPE (figure 3B) , which clearly demonstrates heterozygosity in the carrier mother. One hundred fifty-two chromosomes were examined to determine the frequency of this novel mutation. The frequency was estimated to be <0.007.
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Figure 1. T,-weighted images of the 23-year-old proband. (A) A low cut through the basal ganglia shows increased signal intensity in internal capsule and subcortical white matter compared with the adjacent gray matter, a reversal of the normal pattern. Myelinated white matter has a lower signal intensity than gray matter. (B) A higher cut also shows abnormal signal in the white matter, suggesting a diffuse absence of myelin. These findings were seen throughout the brain.
Discussion. PMD is an X-linked dysmyelinating disorder of the CNS, caused by mutations in PLP.
Here we report a novel mutation in exon 3, Thr 115 Lys. The affected male in this family has a classic PMD phenotype. The mother has adult-onset dementia with severe diffuse abnormality of the white matter, which is either due solely to the PLP mutation, due to a second disorder exacerbated by the PLP mutation, or due to some other disorder entirely unrelated to PLP.
The phenotypic presentation of mutations in PLP extends beyond the characteristic phenotype of PMD to include neurologic disease in women. Two groups have reported white matter abnormalities on cerebral MRI in asymptomatic female carriers of the PMD gene.4*5 Raskind et a1.6 reported mild neurologic abnormalities in a clinically asymptomatic carrier mother and a dementing disorder with gait abnormality in the 80-year-old carrier grandmother of a PMD patient. Maenpaa et al.7 reported developmental delay, spastic quadriplegia, and nystagmus in the cousin Of a PMD patient. Hades et reCentlY identified three unrelated families with sYmP- Figure 2 . era1 neuropathy, cognitive dysfunction, seizures, and motor tract dysfunction (our unpublished data).
We conclude that some mutations in PLP may result in adult-onset dementia in female heterozygotes. Further studies are necessary to elucidate the molecular mechanisms of variable disease expression in women, which could include skewed inactivation of the X chromosome; age-related changes in gene expression; alternative pathways of gene, message, or protein processing; or additional host-specific modulatory genetic or environmental factors.
